NasdaqCM - Delayed Quote USD
SELLAS Life Sciences Group, Inc. (SLS)
At close: November 7 at 4:00 PM EST
After hours: 7:59 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BURNS JOHN THOMAS Chief Financial Officer | Stock Award(Grant) | Jan 22, 2024 | 101,927 |
FRANCOMANO ROBERT Officer | Stock Award(Grant) | Jan 22, 2024 | 40,918 |
KALIN KATHERINE BACH Director | Stock Award(Grant) | Jan 22, 2024 | 8,500 |
SCHEINBERG DAVID A Director | Stock Award(Grant) | Jan 22, 2024 | 10,582 |
STERGIOU ANGELOS M Chief Executive Officer | Stock Award(Grant) | Jan 22, 2024 | 376,421 |
VAN NOSTRAND ROBERT L Director | Stock Award(Grant) | Jan 22, 2024 | 10,400 |
VARIAN JOHN W Director | Stock Award(Grant) | Jan 22, 2024 | 10,400 |
WASMAN JANE Director | Stock Award(Grant) | Jan 22, 2024 | 10,400 |
WOOD BARBARA A General Counsel | Stock Award(Grant) | Jan 22, 2024 | 117,225 |
Related Tickers
EYEN Eyenovia, Inc.
0.4866
-2.72%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9409
+0.85%
ICU SeaStar Medical Holding Corporation
2.5000
-3.85%
ATOS Atossa Therapeutics, Inc.
1.5000
+1.35%
CRDF Cardiff Oncology, Inc.
4.0900
+7.35%
GLSI Greenwich LifeSciences, Inc.
13.81
-4.23%
BCTX BriaCell Therapeutics Corp.
0.7088
+0.54%
ATNM Actinium Pharmaceuticals, Inc.
1.8300
-5.18%
ANVS Annovis Bio, Inc.
8.61
+0.35%
MIST Milestone Pharmaceuticals Inc.
1.9500
+8.94%